CliffBio
small molecule

GONITRO

NITROGLYCERIN

Loss of exclusivityMarch 2032latest FDA-listed patent expiry
CompanyG POHL BOSKAMP GMBH AND CO KG

Drug detail

Brand nameGONITRO
Active ingredientNITROGLYCERIN
Strength0.4MG/PACKET
Dosage formPOWDER
RouteSUBLINGUAL
ModalitySmall molecule
FDA approvalJune 2016
Marketing statusDISCN

Listed patents

PatentExpiresType
9101592March 2032product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

GONITRO patent cliff — loss of exclusivity March 2032 | CliffBio